- Home
- Companies
- TC BioPharm
- Applications
- TCB002 OmnImmune Clinical Trial - ...
TCB002 OmnImmune Clinical Trial - Medical / Health Care
This trial uses our unmodified GDT cells derived from healthy donors, in a dose escalation study to establish safety of the allogeneic platform. This trial is open.
-
Most popular related searches